ADAMTS13 activity and clinical outcomes: a targeted literature review in congenital thrombotic thrombocytopenic purpura and other related thrombotic conditions
Open Access
- 28 May 2026
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 19 (7) , 757-765
Abstract
1. ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13) is a plasma protease that plays a key role in hemostasis by cleaving ultra-large von Willebrand factor (VWF) multimer...Keywords
Funding Information
- Takeda Development Center Americas, Inc., Cambridge, MA, USA
- Baxalta Innovations GmbH, a Takeda company, Vienna, Austria
This publication has 56 references indexed in Scilit:
- Prognostic value of laboratory biomarkers for mortality risk stratification in thrombotic thrombocytopenic purpuraAnnals of Hematology, 2025
- VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in CirrhosisDigestive Diseases and Sciences, 2024
- Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeHepatology International, 2023
- Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 2021
- ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysisJournal of Thrombosis and Thrombolysis, 2019
- Patient Experience with Congenital (Hereditary) Thrombotic Thrombocytopenic Purpura: A Conceptual Framework of Symptoms and ImpactsThe Patient - Patient-Centered Outcomes Research, 2019
- Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot studyInternal and Emergency Medicine, 2016
- ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertensionIndian Journal of Gastroenterology, 2014
- ADAMTS13 content in plasma‐derived factor VIII/von Willebrand factor concentratesAmerican Journal of Hematology, 2013
- Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathiesInternal and Emergency Medicine, 2012